Graber_Emmy_MASS2_web2.JPG Rosacea is in the eye of the beholder, expert says As for treating papules and pustules with oral agents, the strongest evidence favors oral tetracyclines and isotretinoin. Graber_Emmy_MASS2_web2.JPG Topical options for acne patients continue to expand In 2020, clascoterone cream became the first topical androgen receptor inhibitor approved for the treatment of acne in patients aged 12 years and older. Infantile hemangiomas: Accurate diagnosis is crucial Consider propranolol a “life changer” in extreme cases. Managing hyperhidrosis, HS: Ask questions first Ask the patient a simple question: “What bothers you the most?” Psoriasis_NPF_07_web.jpg Recent psoriasis pathophysiology insights carry treatment implications “The primary problem in psoriasis is not so much the inflammatory activity, but the ability to turn off the activity.” Kirkwood_John_Pittsburgh_web.jpg Neoadjuvant immunotherapy shows promise in stage III melanoma There is both preclinical and clinical evidence that neoadjuvant therapy may offer a survival advantage over adjuvant therapy. Hypochlorous acid is a valuable adjunctive treatment in AD Stabilized topical hypochlorous acid has potent antimicrobial and antipruritic effects. Strober_Bruce_CT_web.jpg Deucravacitinib offers biologic-like psoriasis efficacy in oral form Novel anti-inflammatory mechanism involves selective TYK2 inhibition. Wang_Steven_web.jpg Telltale dermoscopic features of melanomas lacking pigment reviewed Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma. Bhatia_Neal_CA_web.jpg New AK treatments: Local reactions are the price for greater clearance rates Like current treatments effective for actinic keratosis, coming therapies are likely to trade tolerability for efficacy. Pages« first ‹ previous 1 2 3 4 5 6 7 8 9 … next › last »